Bioverativ

ALPROLIX

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Bioverativ

Alprolix HCPCS:

J7201

HCPCS Code Descriptor:

Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.

Category:

J Code

Alprolix NDCs:

71104-0977-01, 71104-0933-01, 71104-0966-01, 71104-0944-01, 71104-0911-01, 71104-0922-01

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Alprolix CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Alprolix:

ALPROLIX is a Hematology drug manufactured by Bioverativ and administered via the Intravenous route of administration. The J Code: J7201 is aligned to the drug ALPROLIX.

ACCESS PRICING AND MORE BY REGISTERING

J7201 Added Date:

January 1, 2015

J7201 Effective Date:

January 1, 2017

J7201 Termination Date:

HCPCS Active

Alprolix billing and coding information can be found through Bioverativ at the link below:
Alprolix patient assistance information can be found through Sanofi at the URL: https://www.alprolix.com/resources/financial-assistance.aspx
ALPROLIX prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for ALPROLIX. Please check back in a few weeks.